カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の慢性心不全(CHF)治療装置市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Chronic Heart Failure (CHF) Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY7710）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY7710
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の慢性心不全(CHF)治療装置市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

慢性心不全(CHF)治療装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の慢性心不全(CHF)治療装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

慢性心不全(CHF)治療装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・植込み型左室補助循環装置（LVAD）、両室ペースメーカー、植込み型除細動器（ICD）、持続陽圧装置（CPAP）、二段階陽圧装置（BiPAP）、心臓ポンプ

用途別セグメントは次のように区分されます。
・病院、クリニック、家庭用、その他

世界の慢性心不全(CHF)治療装置市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic、Abbott、Johnson & Johnson、Stanley Pharmaceuticals、New Haven Pharmaceuticals, Inc.、Boston Scientific Corporation、HeartWare、Biovail Corporation、Abiomed、Symplmed Pharmaceuticals、Berlin Heart GmbH、ReliantHeart, Inc.、Cardiokinetix、Biotronik、Jarvik Heart

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、慢性心不全(CHF)治療装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な慢性心不全(CHF)治療装置メーカーの企業概要、2019年～2022年までの慢性心不全(CHF)治療装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な慢性心不全(CHF)治療装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別慢性心不全(CHF)治療装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの慢性心不全(CHF)治療装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での慢性心不全(CHF)治療装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および慢性心不全(CHF)治療装置の産業チェーンを掲載しています。
・第13、14、15章では、慢性心不全(CHF)治療装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Medtronic、Abbott、Johnson & Johnson、Stanley Pharmaceuticals、New Haven Pharmaceuticals, Inc.、Boston Scientific Corporation、HeartWare、Biovail Corporation、Abiomed、Symplmed Pharmaceuticals、Berlin Heart GmbH、ReliantHeart, Inc.、Cardiokinetix、Biotronik、Jarvik Heart
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：植込み型左室補助循環装置（LVAD）、両室ペースメーカー、植込み型除細動器（ICD）、持続陽圧装置（CPAP）、二段階陽圧装置（BiPAP）、心臓ポンプ
・用途別分析2017年-2028年：病院、クリニック、家庭用、その他
・慢性心不全(CHF)治療装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・慢性心不全(CHF)治療装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・慢性心不全(CHF)治療装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・慢性心不全(CHF)治療装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・慢性心不全(CHF)治療装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Chronic Heart Failure (CHF) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Chronic Heart Failure (CHF) Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Chronic Heart Failure (CHF) Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Implantable Left Ventricular Assist Device (LVAD) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Chronic Heart Failure (CHF) Devices include Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, and New Haven Pharmaceuticals, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Chronic Heart Failure (CHF) Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Market segment by Application can be divided into
Hospital
Clinic
Household
Others
The key market players for global Chronic Heart Failure (CHF) Devices market are listed below:
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Heart Failure (CHF) Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Heart Failure (CHF) Devices, with price, sales, revenue and global market share of Chronic Heart Failure (CHF) Devices from 2019 to 2022.
Chapter 3, the Chronic Heart Failure (CHF) Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Heart Failure (CHF) Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chronic Heart Failure (CHF) Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Heart Failure (CHF) Devices.
Chapter 13, 14, and 15, to describe Chronic Heart Failure (CHF) Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Chronic Heart Failure (CHF) Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Heart Failure (CHF) Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Implantable Left Ventricular Assist Device (LVAD)
1.2.3 Biventricular Pacemaker
1.2.4 Implantable Cardioverter-defibrillators (ICDs)
1.2.5 Continuous Positive Air Pressure Device (CPAP)
1.2.6 Bi-level Positive Air Pressure Device (BiPAP)
1.2.7 Heart Pumps
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Heart Failure (CHF) Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global Chronic Heart Failure (CHF) Devices Market Size & Forecast
1.4.1 Global Chronic Heart Failure (CHF) Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Chronic Heart Failure (CHF) Devices Sales in Volume (2017-2028)
1.4.3 Global Chronic Heart Failure (CHF) Devices Price (2017-2028)
1.5 Global Chronic Heart Failure (CHF) Devices Production Capacity Analysis
1.5.1 Global Chronic Heart Failure (CHF) Devices Total Production Capacity (2017-2028)
1.5.2 Global Chronic Heart Failure (CHF) Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Heart Failure (CHF) Devices Market Drivers
1.6.2 Chronic Heart Failure (CHF) Devices Market Restraints
1.6.3 Chronic Heart Failure (CHF) Devices Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Chronic Heart Failure (CHF) Devices Product and Services
2.1.4 Medtronic Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Chronic Heart Failure (CHF) Devices Product and Services
2.2.4 Abbott Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product and Services
2.3.4 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Stanley Pharmaceuticals
2.4.1 Stanley Pharmaceuticals Details
2.4.2 Stanley Pharmaceuticals Major Business
2.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product and Services
2.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 New Haven Pharmaceuticals, Inc.
2.5.1 New Haven Pharmaceuticals, Inc. Details
2.5.2 New Haven Pharmaceuticals, Inc. Major Business
2.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product and Services
2.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business
2.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product and Services
2.6.4 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HeartWare
2.7.1 HeartWare Details
2.7.2 HeartWare Major Business
2.7.3 HeartWare Chronic Heart Failure (CHF) Devices Product and Services
2.7.4 HeartWare Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biovail Corporation
2.8.1 Biovail Corporation Details
2.8.2 Biovail Corporation Major Business
2.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Product and Services
2.8.4 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abiomed
2.9.1 Abiomed Details
2.9.2 Abiomed Major Business
2.9.3 Abiomed Chronic Heart Failure (CHF) Devices Product and Services
2.9.4 Abiomed Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Symplmed Pharmaceuticals
2.10.1 Symplmed Pharmaceuticals Details
2.10.2 Symplmed Pharmaceuticals Major Business
2.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product and Services
2.10.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Berlin Heart GmbH
2.11.1 Berlin Heart GmbH Details
2.11.2 Berlin Heart GmbH Major Business
2.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product and Services
2.11.4 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ReliantHeart, Inc.
2.12.1 ReliantHeart, Inc. Details
2.12.2 ReliantHeart, Inc. Major Business
2.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product and Services
2.12.4 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Cardiokinetix
2.13.1 Cardiokinetix Details
2.13.2 Cardiokinetix Major Business
2.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Product and Services
2.13.4 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Biotronik
2.14.1 Biotronik Details
2.14.2 Biotronik Major Business
2.14.3 Biotronik Chronic Heart Failure (CHF) Devices Product and Services
2.14.4 Biotronik Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jarvik Heart
2.15.1 Jarvik Heart Details
2.15.2 Jarvik Heart Major Business
2.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Product and Services
2.15.4 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Chronic Heart Failure (CHF) Devices Breakdown Data by Manufacturer
3.1 Global Chronic Heart Failure (CHF) Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Chronic Heart Failure (CHF) Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Chronic Heart Failure (CHF) Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Heart Failure (CHF) Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Chronic Heart Failure (CHF) Devices Manufacturer Market Share in 2021
3.5 Global Chronic Heart Failure (CHF) Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Chronic Heart Failure (CHF) Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Heart Failure (CHF) Devices Market Size by Region
4.1.1 Global Chronic Heart Failure (CHF) Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Chronic Heart Failure (CHF) Devices Revenue by Region (2017-2028)
4.2 North America Chronic Heart Failure (CHF) Devices Revenue (2017-2028)
4.3 Europe Chronic Heart Failure (CHF) Devices Revenue (2017-2028)
4.4 Asia-Pacific Chronic Heart Failure (CHF) Devices Revenue (2017-2028)
4.5 South America Chronic Heart Failure (CHF) Devices Revenue (2017-2028)
4.6 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Chronic Heart Failure (CHF) Devices Sales in Volume by Type (2017-2028)
5.2 Global Chronic Heart Failure (CHF) Devices Revenue by Type (2017-2028)
5.3 Global Chronic Heart Failure (CHF) Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Chronic Heart Failure (CHF) Devices Sales in Volume by Application (2017-2028)
6.2 Global Chronic Heart Failure (CHF) Devices Revenue by Application (2017-2028)
6.3 Global Chronic Heart Failure (CHF) Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Heart Failure (CHF) Devices Sales by Type (2017-2028)
7.2 North America Chronic Heart Failure (CHF) Devices Sales by Application (2017-2028)
7.3 North America Chronic Heart Failure (CHF) Devices Market Size by Country
7.3.1 North America Chronic Heart Failure (CHF) Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Chronic Heart Failure (CHF) Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Heart Failure (CHF) Devices Sales by Type (2017-2028)
8.2 Europe Chronic Heart Failure (CHF) Devices Sales by Application (2017-2028)
8.3 Europe Chronic Heart Failure (CHF) Devices Market Size by Country
8.3.1 Europe Chronic Heart Failure (CHF) Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Chronic Heart Failure (CHF) Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Chronic Heart Failure (CHF) Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Chronic Heart Failure (CHF) Devices Market Size by Region
9.3.1 Asia-Pacific Chronic Heart Failure (CHF) Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Chronic Heart Failure (CHF) Devices Sales by Type (2017-2028)
10.2 South America Chronic Heart Failure (CHF) Devices Sales by Application (2017-2028)
10.3 South America Chronic Heart Failure (CHF) Devices Market Size by Country
10.3.1 South America Chronic Heart Failure (CHF) Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Chronic Heart Failure (CHF) Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Chronic Heart Failure (CHF) Devices Market Size by Country
11.3.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Chronic Heart Failure (CHF) Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Chronic Heart Failure (CHF) Devices
12.3 Chronic Heart Failure (CHF) Devices Production Process
12.4 Chronic Heart Failure (CHF) Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Chronic Heart Failure (CHF) Devices Typical Distributors
13.3 Chronic Heart Failure (CHF) Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の慢性心不全(CHF)治療薬市場2022年：市場規模予測（～2028年）
  • うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他
  • 世界の埋め込み型補助人工心臓（VAD）市場2022年：市場規模予測（～2028年）
  • 世界のシングルローラーポンプ人工心臓肺機市場2022年：市場規模予測（～2028年）
  • 世界のダブルローラーポンプ人工心臓肺マシン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY7710 )"世界の慢性心不全(CHF)治療装置市場2022年：市場規模予測（～2028年）" (英文：Global Chronic Heart Failure (CHF) Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。